Objective

2

To observe the clinical efficacy of the

Tongyuan

acupuncture technique combined with

Ruhesanjie Tablets

in the treatment of liver depression and phlegm stagnation-type hyperplasia of mammary glands （HMG）.

Methods

2

A total of 66 female patients with HMG who visited the Department of Acupuncture and Moxibustion Rehabilitation or the Breast Department （outpatient and

inpatient） of AffiliatedGuangzhou Hospital of Traditional Chinese Medicine， Guangzhou University of Chinese Medicine， between July 2023 and January 2024， were selected and randomly divided into an observation group and a control group using a random number table. Both groups received basic treatment. The control group was treated with oral

Ruhesanjie Tablets

， while the observation group received

Tongyuan

acupuncture combined with oral

Ruhesanjie Tablets

. Visual Analogue Scale （VAS） scores for pain， Patient Health Questionnaire-9 （PHQ-9） scores， local breast symptom scores，traditional Chinese medicine （TCM） syndrome scores， clinical efficacy， and safety were compared between the two groups before and after treatment.

Results

2

At the end of treatment and at week 4 after treatment， VAS scores， PHQ-9 scores， local breast symptom scores， and TCM syndrome scores in both groups were significantly lower than those before treatment （

P

<

0.05，

P

<

0.01）， and the reductions in the observation group were significantly greater than those in the control group （

P

<

0.05，

P

<

0.01）. The overall efficacy in the observation group was significantly superior to that in the control group （

P

<

0.05）. During the treatment， all patients in both groups remained stable in vital signs， with no adverse reactions observed， indicating good safety.

Conclusion

2

Tongyuan

acupuncture combined with

Ruhesanjie Tablets

is significantly effective in treating liver depression and phlegm stagnation-type HMG. It can improve both clinical and local symptoms and demonstrates superior efficacy compared to

Ruhesanjie Tablets

alone.